DK568584A - Azabicyclo(3,3,1)nonan-9-oner eller stereoisomere eller farmaceutiskacceptable syreadditionssalte deraf, deres fremstilling og anvendelse samt mellemprodukter til fremstillingen - Google Patents

Azabicyclo(3,3,1)nonan-9-oner eller stereoisomere eller farmaceutiskacceptable syreadditionssalte deraf, deres fremstilling og anvendelse samt mellemprodukter til fremstillingen Download PDF

Info

Publication number
DK568584A
DK568584A DK568584A DK568584A DK568584A DK 568584 A DK568584 A DK 568584A DK 568584 A DK568584 A DK 568584A DK 568584 A DK568584 A DK 568584A DK 568584 A DK568584 A DK 568584A
Authority
DK
Denmark
Prior art keywords
azabicyclo
nonane
stereoisomers
ones
preparation
Prior art date
Application number
DK568584A
Other languages
English (en)
Other versions
DK568584D0 (da
Inventor
Karoly Nador
Gabor Kraiss
Margit Pellinoisz
Egon Karpati
Laszlo Szporny
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of DK568584D0 publication Critical patent/DK568584D0/da
Publication of DK568584A publication Critical patent/DK568584A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DK568584A 1983-11-30 1984-11-29 Azabicyclo(3,3,1)nonan-9-oner eller stereoisomere eller farmaceutiskacceptable syreadditionssalte deraf, deres fremstilling og anvendelse samt mellemprodukter til fremstillingen DK568584A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU834096A HU190511B (en) 1983-11-30 1983-11-30 Process for preparing new azabicyclic compounds

Publications (2)

Publication Number Publication Date
DK568584D0 DK568584D0 (da) 1984-11-29
DK568584A true DK568584A (da) 1985-05-31

Family

ID=10966876

Family Applications (1)

Application Number Title Priority Date Filing Date
DK568584A DK568584A (da) 1983-11-30 1984-11-29 Azabicyclo(3,3,1)nonan-9-oner eller stereoisomere eller farmaceutiskacceptable syreadditionssalte deraf, deres fremstilling og anvendelse samt mellemprodukter til fremstillingen

Country Status (31)

Country Link
US (1) US4769373A (da)
JP (1) JPS60185766A (da)
AR (1) AR241492A1 (da)
AT (1) AT388730B (da)
AU (1) AU570285B2 (da)
BE (1) BE901174A (da)
CA (1) CA1280751C (da)
CH (1) CH663615A5 (da)
CS (1) CS273602B2 (da)
DD (1) DD231073A1 (da)
DE (1) DE3442365A1 (da)
DK (1) DK568584A (da)
EG (1) EG16845A (da)
ES (2) ES8604579A1 (da)
FI (1) FI80445C (da)
FR (1) FR2555580B1 (da)
GB (1) GB2150558B (da)
GR (1) GR81084B (da)
HU (1) HU190511B (da)
IL (1) IL73421A (da)
IT (1) IT1178638B (da)
MX (1) MX157611A (da)
NL (1) NL8403634A (da)
NO (1) NO165292C (da)
PH (1) PH19659A (da)
PL (2) PL144546B1 (da)
PT (1) PT79568B (da)
SE (1) SE460418B (da)
SU (1) SU1395141A3 (da)
YU (1) YU45681B (da)
ZA (1) ZA848721B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0525672D0 (en) * 2005-12-16 2006-01-25 Novartis Ag Organic compounds
CN111187210B (zh) * 2020-01-08 2022-05-03 成都中医药大学 一种热解型二萜生物碱化合物及其制备方法和用途
CN113149906B (zh) * 2021-02-24 2022-05-17 成都中医药大学 一种抗心律失常药物及其制备方法
CN113149905B (zh) * 2021-02-24 2022-04-29 成都中医药大学 一种抗心律失常的化合物及其制药用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1195746A (en) * 1967-06-07 1970-06-24 Yoshitomi Pharmaceutical 3-Azabicyclo [3,3,1] Nonane Derivatives
US3740408A (en) * 1967-09-11 1973-06-19 Upjohn Co Oxygenated 3-aza bicyclo(3,3,1)nonanes
GB1393253A (en) * 1971-09-10 1975-05-07 Wyeth John & Brother Ltd 3-azabicyclo-3,3,1-nonanes

Also Published As

Publication number Publication date
GB2150558A (en) 1985-07-03
FI844480L (fi) 1985-05-31
CS273602B2 (en) 1991-03-12
EG16845A (en) 1990-12-30
SE8406046D0 (sv) 1984-11-29
PL254457A1 (en) 1987-03-23
ZA848721B (en) 1985-06-26
NO165292C (no) 1991-01-23
CS920184A2 (en) 1990-08-14
GR81084B (en) 1985-03-29
AR241492A1 (es) 1992-07-31
FI844480A0 (fi) 1984-11-15
SE8406046L (sv) 1985-05-31
CH663615A5 (de) 1987-12-31
DE3442365A1 (de) 1985-06-05
GB2150558B (en) 1987-10-14
HU190511B (en) 1986-09-29
PL142604B1 (en) 1987-11-30
FR2555580B1 (fr) 1988-10-28
BE901174A (fr) 1985-05-30
NL8403634A (nl) 1985-06-17
MX157611A (es) 1988-12-05
CA1280751C (en) 1991-02-26
NO165292B (no) 1990-10-15
AU3602984A (en) 1985-06-06
FI80445B (fi) 1990-02-28
PT79568B (en) 1986-09-11
IT8423805A0 (it) 1984-11-29
ES8606338A1 (es) 1986-04-01
JPS60185766A (ja) 1985-09-21
ES548112A0 (es) 1986-04-01
IL73421A (en) 1987-12-31
PT79568A (en) 1984-12-01
AU570285B2 (en) 1988-03-10
NO844750L (no) 1985-05-31
PL250635A1 (en) 1985-11-05
FR2555580A1 (fr) 1985-05-31
ES8604579A1 (es) 1986-02-01
IT1178638B (it) 1987-09-09
DK568584D0 (da) 1984-11-29
FI80445C (fi) 1990-06-11
SU1395141A3 (ru) 1988-05-07
YU45681B (sh) 1992-07-20
SE460418B (sv) 1989-10-09
US4769373A (en) 1988-09-06
DD231073A1 (de) 1985-12-18
HUT35647A (en) 1985-07-29
YU200684A (en) 1987-10-31
PH19659A (en) 1986-06-09
GB8428143D0 (en) 1984-12-12
ATA352184A (de) 1989-01-15
ES538069A0 (es) 1986-02-01
AT388730B (de) 1989-08-25
PL144546B1 (en) 1988-06-30

Similar Documents

Publication Publication Date Title
DK164902C (da) 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-quinolincarboxylsyrederivater eller farmaceutisk acceptable syreadditionssalte deraf samt laegemiddel indeholdende disse forbindelser og fremgangsmaade til midlets fremstilling
DK298984A (da) Tetrahydropyridazinoner eller syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler samt mellemprodukter og disses fremstilling
DK159848C (da) 7-hydroxy-1,2,3,4,4a,5,6,10b-oktahydrobenzo(f)-quinoliner eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutiske praeparater indeholdende saadanne forbindelser
DK448784A (da) Pyridoindoler, eller syreadditionssalte deraf, deres fremstilling ogmellemprodukter hertil samt deres anvendelse
DK131887A (da) 1,2,3,4-tetrahydro-3-carbamoyl-2-thioxo/oxo-5-pyrimidencarboxylsyre-derivater og deres anvendelse som laegemidler
DK170986D0 (da) Substituerede 2,3,4,9-tetrahydro-1h-carbazol-1-eddikesyre-derivater, deres fremstilling og anvendelse som farmaceutika samt mellemprodukterved fremstillingen
DK103987D0 (da) Substituerede 1,3,4,9-tetrahydropyranooe3,4-baaindol-l-eddikesyrer, deres fremstilling og anvendelse som laegemidler
DK477685A (da) Peptidsubstituerede heterocycliske forbindelser og anvendelse deraf som immunostimulerende eller antiinfektive forbindelser samt farmaceutiske praeparater
DK144885A (da) Substituerede 4-hydroxybenzopyraner eller farmaceutisk acceptable additionssalte deraf, deres fremstilling og anvendelse som laegemidler
DK568584D0 (da) Azabicyclo(3,3,1)nonan-9-oner eller stereoisomere eller farmaceutiskacceptable syreadditionssalte deraf, deres fremstilling og anvendelse samt mellemprodukter til fremstillingen
DK624186D0 (da) 6h-isoxazolo(5,4-d)pyrazolo(3,4-6)pyridiner eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler samt mellemprodukter til fremstillingen
DK587689D0 (da) 2-azabicyclo(2,2,1)hept-5-en-2-eddikesyre og derivater deraf, deres fremstilling og anvendelse
DK317184A (da) 2-azabicyclo(2,2,2)octanderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse som farmaceutika
DK410185D0 (da) 7-oxo-4-thia-1-azabicyclo(3,2,0)hept-2-en-derivater, deres fremstilling og anvendelse som laegemiddel, samt ved fremstillingen anvendelige mellemprodukter
DK393185D0 (da) Fluoralkoxyphenylsulfonylguanidiner eller syreadditionsprodukter deraf, deres fremstilling og anvendelse som herbicider
DK192588A (da) Pyrrolaldehyder eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse
DK454987A (da) 2,3-dihydro-1h-phenalen-2-aminoforbindelser eller syreadditionssalte deraf samt farmaceutiske praeparater indeholdende dem
DK394085D0 (da) Substituerede arylsulfonylguanidiner eller additionsprodukter deraf,deres fremstilling og anvendelse som herbicider
DK523289A (da) 2,3,5,6-tetrahydro(1,3,6)triazocino(1,2-a)benzim- idazoler eller farmaceutisk acceptable syreadditionssalte deraf og deres anvendelse
DK581487A (da) 2,6-diamino-3-halogenbenzylpyridiner og fremgangsmaade til deres fremstilling samt deres anvendelse i laegemidler
DK238786A (da) Bicycliske aminosyrer eller fysiologiske uskadelige salte deraf, deres fremstilling og anvendelse som laegemidler samt mellemprodukter til fremstillingen og disses fremstilling
DK180086D0 (da) 12b-substituerede 1-hydroxymethyl-octahydroindolo(2,3-a)-quinolizinderivater eller isomere eller syreadditionssalte deraf, deres fremstilling og anvendelse som farmaceutika
DK92582A (da) Alkylendiaminderivater n-oxider eller syreadditionssalte deraf deres fremstilling og anvendelse som antiarytmiske laegemidler
DK44487A (da) 1-(3-(2-hydroxy-3-alkylaminopropoxy)-2-thienyl)-3-phenyl-1-propanon eller syreadditionssalt deraf samt fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende en saadan forbindelse
DK254983D0 (da) 4-aryl-2-methyl-1,2,3,4-tetrahydroisoquinolinderivater eller syreadditionssalte deraf og fremgangsmade til deres fremstilling

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment